Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval
My take on this is counter-consensus. I don't believe that screening drugs based on effectiveness is a proper role for any government agency. There is a role for them to guard against fraud and to protect rights, but not to prevent people from making risky choices. Adults should not be protected from the decision to take any drug, however harmful, even if instantly fatal, if fraud or force is not involved.These are extraordinarily complex choices that seldom have a right answer for all possible patients. Therefore they should not be made centrally for everyone. We will learn more and faster from decentralized decision makers, that is, from massively parallel computation from a mass population of decision makers.Better would be for the only role of the FDA in decisions like this to be determining if the manufacturer is making fraudulent claims. Even better (because of greater computational parallelism) would be for this to be legally decided only by individual states. Best would be to treat adults as adults, and let them and their medical providers make such choices.